During a coronavirus press briefing on Tuesday, US President Donald Trump said that antimalarial drug Hydroxychloroquine is safe during the early stages of COVID-19 infection.
“Many doctors think it is extremely successful – the hydroxychloroquine, coupled with the zinc, and perhaps the azithromycin. Many doctors think it’s extremely good and many people don’t … I think it’s become very political. I happen to believe in it. I would take it. As you know, I took it for a 14 day period and I’m here,” Trump said during the briefing.
“It’s safe, it doesn’t cause problems. I had no problem. I had absolutely no problem,” Trump continued, also noting that “from a safety standpoint, it’s safe.”
“[The] FDA has determined that CQ [ chloroquine phosphate] and HCQ [hydroxychloroquine sulfate] are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA [Emergency Use Authorization]. Additionally, in light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer outweigh the known and potential risks for the authorized use. This warrants revocation of the EUA for HCQ and CQ for the treatment of COVID-19,” the FDA wrote in a June 15 alert.
Trump Addresses Retweets of Houston Doctor
In addition to praising hydroxychloroquine, Immanuel, who is a registered physician in Texas, also believes that face masks are not needed to stop the transmission of COVID-19. She has also made questionable claims that some gynecological issues arise as a result of people having sex with witches and demons in their dreams.
Administration Invokes Defense Production Act
During the briefing, Trump also revealed that US photography company Kodak has won a $765 million government loan under the Defense Production Act to help speed up the domestic production of pharmaceuticals and decrease the US’ reliance on other countries, namely China, for drugs.
According to the Wall Street Journal, which first broke the news, the loan is from the US International Development Finance Corporation and is the first of its kind under the Defense Production Act, which the Trump administration tapped on to expedite the production of COVID-19 related equipment like ventilators.